Organization
Kagawa University Hospital
3 abstracts
Abstract
Association of baseline characteristics with adverse events (AEs) in the PROpel trial of olaparib (ola) plus abiraterone (abi) as first-line (1L) treatment for metastatic castration-resistant prostate cancer (mCRPC).Org: Centre Hospitalier de l’Université de Montréal/CRCHUM, Centro Integrado de Oncologia de Curitiba, Radboud Universitair Medisch Centrum, Southampton General Hospital, Centre Hospitalier de Quimper,
Abstract
New concept infusion pump with an anticancer drug exposure prevention function.Org: Department of Clinical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Faculty of Medicine, Cairo University, Kagawa University Hospital,
Abstract
ANEMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK INHIBITORSOrg: Sanuki municipal hospital, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Kagawa University Hospital, Japan Association for Development of Community Medicine,